National Supply Status for Injectables Portrait national de la disponibilité des injectables Supply Status/ Disponibilité du produit

Transcription

1 National Status for Injectables Date de rupture de stock 1020 ACETYLCYSTEINE Sol 200mg/mL 10mLV P OA AV 1030 ACETYLCYSTEINE Sol 200mg/mL 30mLV P OA BO Mid / mi ALCOHOL (DEHYDRATED) Inj 100% 5x10mLV D 0% EM N/A Available for emergencies, direct order only via EAO process Disponible pour les urgences, commande directe seulement via le formulaire CEA 1260 AMIKACIN SO4 Inj 250mg/mL 10x2mLV P OA AV 1282 AMIODARONE HCl for Inj 50mg/mL 10x3mLV P OA AV 1284 AMIODARONE HCl for Inj 50mg/mL 18mLV P OA BO Q AMIODARONE HCl for Inj 50mg/mL 9mLV P OA ABO Mid / mi AMIODARONE SYRINGE for Inj 50mg/mL 1x3mL P OA AV 1091 ATROPINE SO4 Inj 0.4mg/mL 10x1mLA P OA AV 1101 ATROPINE SO4 Inj 0.6mg/mL 10x1mLA P OA AV 1650 BRETYLIUM Tos Inj 50mg/mL 5x10mLV P OA BO End / Fin CEFAZOLIN for Inj 10gV P OA AV CEFAZOLIN for Inj 10x1gV P OA AV CEFAZOLIN for Inj 10x500mgV P OA AV CEFTRIAXONE for Inj 10gV P OA AV CEFTRIAXONE for Inj 10x0.25gV P OA BO End / Fin CEFTRIAXONE for Inj 10x1gV P OA AV CEFTRIAXONE for Inj 10x2gV P OA AV CIPROFLOXACIN Inj 200mg 10x100mL Minibag P OA AV CIPROFLOXACIN Inj 400mg 10x200mL Minibag P OA AV CISPLATIN Inj 1mg/mL 100mLV P OA AV CISPLATIN Inj 1mg/mL 50mLV P OA AV CLINDAMYCIN Inj 150mg/mL 10x2mLA S OA BO TBD 2050 CLINDAMYCIN Inj 150mg/mL 10x2mLV P OA AV 2060 CLINDAMYCIN Inj 150mg/mL 10x4mLV P OA AV 2070 CLINDAMYCIN Inj 150mg/mL 10x6mLV S OA BO TBD 2090 CLINDAMYCIN Inj 150mg/mL 120mLV D OA ABO N/A CLINDAMYCIN Inj 150mg/mL 60mLV P OA AV CLINDAMYCIN Inj 600mg 10x50mL Minibag P OA AV CLINDAMYCIN Inj 900mg 10x50mL Minibag P OA AV CLINDAMYCIN Inj.150mg/mL 10x4mLA S OA BO TBD 1812 CODEINE PO4 Inj 30mg/mL 10x1mLA P OA AV 2291 DEXAMETHASONE Inj 10mg/mL 10x1mLV P OA AV 2301 DEXAMETHASONE Inj 4mg/mL 10x5mLV P OA AV 7900 DIAZEPAM Inj 5mg/mL 10x2mLA P OA AV DIAZEPAM Inj. 5mg/mL 10x2mLA S OA BO TBD DIGOXIN Inj 0.25mg/mL 10x2mLA P OA AV DILTIAZEM HCl Inj 5mg/mL 10x10mLV P OA AV DILTIAZEM HCl Inj 5mg/mL 10x5mLV P OA AV 5901 DIMENHYDRINATE IM Inj 50mg/mL 10x1mLA P OA AV 5841 DIMENHYDRINATE IM Inj 50mg/mL 10x5mLV P OA AV 5831 DIMENHYDRINATE IV Inj 10mg/mL 10x5mLV P OA AV Page 1

2 National Status for Injectables Date de rupture de stock 2400 DIPHENHYDRAMINE HCl Inj 50mg/mL 10x1mLV P OA BO Q DIPHENHYDRAMINE HCl Inj 50mg/mL 10x1mLV S OA BO TBD DOBUTAMINE Inj 12.5mg/mL 10x20mLA S OA BO TBD DOBUTAMINE Inj 12.5mg/mL 10x20mLV P OA AV DOCETAXEL Inj 10 mg/ml 16mLV P OA AV DOXORUBICIN HCL Inj 2 mg/ml 25 mlv P OA AV DOXORUBICIN HCL Inj 2 mg/ml 5x5mLV S OA BO TBD 2420 EPHEDRINE SO4 Inj 50mg/mL 10x1mLA P OA AV ETOPOSIDE for Inj 20mg/mL 10mLV P OA BO Mid / mi ETOPOSIDE for Inj 20mg/mL 25mLV P OA BO Mid / mi ETOPOSIDE for Inj 20mg/mL 50mLV P OA AV ETOPOSIDE for Inj 20mg/mL 5mLV P OA BO Mid / mi FENTANYL Cit Inj 50mcg/mL 10x10mLV P OA AV FENTANYL Cit Inj 50mcg/mL 10x2mLA P OA AV 2520 FENTANYL Cit Inj 50mcg/mL 10x2mLA P OA AV FENTANYL Cit Inj 50mcg/mL 10x5mLV P OA AV 2560 FENTANYL Cit Inj 50mcg/mL 50mLV P OA AV 2540 FENTANYL Cit Inj 50mcg/mL 5x10mLV S OA BO N/A FENTANYL Cit Inj 50mcg/mL 5x20mLV P OA AV FENTANYL Cit Inj. 50mcg/mL 5x10mLA S OA BO TBD FLUCONAZOLE Inj 2mg/mL 100mLV P OA AV 2490 FLUCONAZOLE Inj 2mg/mL 100mLV S OA BO TBD 2630 FLUMAZENIL Inj 0.1mg/mL 10x5mLV P OA AV FLUOROURACIL Inj 50mg/mL 100mLV P 75% AV FLUOROURACIL Inj 50mg/mL 100mLV S OA BO N/A FUROSEMIDE 10MG/ML 4ML 10LIAM CA P OA BO End / Fin FUROSEMIDE Inj 10mg/mL 10x2mLA S OA BO TBD FUROSEMIDE Inj 10mg/mL 10x4mLV P OA BO End / Fin FUROSEMIDE Inj. 10mg/mL 10x2mLA P OA BO End / Fin FUROSEMIDE SPECIAL Inj 10mg/mL 10x25mLV P 50% AV End / Fin Gemcitabine HCL for Inj 40mg/mL 1x25mLV P OA AV Gemcitabine HCL for Inj 40mg/mL 1x50mLV P OA AV Gemcitabine HCL for Inj 40mg/mL 5x5mLV P OA AV 2780 GENTAMICIN Inj 10mg/mL 10x2mLV P 50% AV 2800 GENTAMICIN Inj 40mg/mL 10x2mLV P 100% AV 2810 GENTAMICIN Inj 40mg/mL 20mLV P 100% AV 2871 GLYCOPYRROLATE Inj 0.2mg/mL 10x2mLV P OA AV 2880 GLYCOPYRROLATE Inj 0.2mg/mL 20mLV P OA AV 2900 HALOPERIDOL Inj 5mg/mL 10x1mLA P OA AV Page 2

3 National Status for Injectables Sandoz Date de rupture de stock 2940 HALOPERIDOL LA Inj 100mg/mL 5mLV P OA AV HEPARIN Na U/mL 50mLV P OA AV HEPARIN Na Inj 10,000U/mL 10x1mLV P OA AV HEPARIN Na Inj 10,000U/mL 10x5mLV P OA AV HEPARIN Na Inj 1000U/mL 10x10mLV P OA AV HEPARIN Na Inj 1000U/mL 10x30mLV P OA AV 4021 HYDROMORPHONE HCl Inj 2mg/mL 10x1mLA P OA AV 4152 HYDROMORPHONE HP FORTE Inj 10mLV P OA BO Q HYDROMORPHONE HP10 Inj 10x1mLV P OA AV HYDROMORPHONE HP10 Inj 10x5mLV P OA AV 4061 HYDROMORPHONE HP10 Inj 50mLV P OA AV 4101 HYDROMORPHONE HP20 Inj 50mLV P OA AV 4111 HYDROMORPHONE HP50 Inj 10x1mLV P OA AV 4141 HYDROMORPHONE HP50 Inj 50mLV P OA AV 3000 HYDROXYZINE HCl Inj 50mg/mL 10x1mLA P OA AV 3200 HYOSCINE Butylbr Inj 20mg/mL 10x1mLV P OA AV IMIPENEM/CILASTATIN for Inj 10x250mgV P OA AV IMIPENEM/CILASTATIN for Inj 10x500mgV P OA AV IRINOTECAN HCl Inj 20mg/mL 5x2mLV S OA BO TBD IRINOTECAN HCl Inj 20mg/mL 5x5mLV S OA BO TBD IRINOTECAN HCl Inj. 20mg/mL 25mLV S OA BO TBD 4600 ISOPROTERENOL HCl Inj 0.2mg/mL 10x1mLA P OA AV KETAMINE HCl Inj 10mg/mL 10x2mLV P OA AV 4550 KETAMINE HCl Inj 10mg/mL 20mLV P OA AV 4560 KETAMINE HCl Inj 50mg/mL 10mLV P OA AV KETAMINE HCl Inj 50mg/mL 10x2mLA S OA BO TBD KETAMINE HCl Inj 50mg/mL 10x2mLV P OA AV 4640 KETOROLAC Trometh Inj 30mg/mL 10x1mLV P OA AV 4660 LABETALOL HCl Inj 5mg/mL 20mLV P OA AV LORAZEPAM Inj 2mg/mL 10x1mLV P OA AV 4970 LORAZEPAM Inj 4mg/mL 10x1mLV P OA AV 5000 LOXAPAC IM Inj 50mg/mL 10x1mLA P OA AV 2201 MEPERIDINE HCl Inj 50mg/mL 10x1mLA P OA AV MEROPENEM for Injection 10x1g/V P OA AV MEROPENEM for Injection 10x500mg/V P OA AV METHOTREXATE Inj 25mg/mL 20mLV P OA AV METHOTREXATE Inj 25mg/mL 2mLV P OA BO End / Fin METOCLOPRAMIDE HCl Inj 5mg/mL 10x2mLV P OA AV 5220 METOCLOPRAMIDE HCl Inj 5mg/mL 30mLV P OA AV METOPROLOL Tart Inj 1mg/mL 10x5mLV P OA AV 5250 MIDAZOLAM Inj 1mg/mL 10x10mLV P OA AV MIDAZOLAM Inj 1mg/mL 10x2mLA S OA BO TBD MIDAZOLAM Inj 1mg/mL 10x2mLV P OA AV 5240 MIDAZOLAM Inj 1mg/mL 10x5mLV P OA AV Page 3

4 National Status for Injectables 5280 MIDAZOLAM Inj 5mg/mL 10x10mLV P OA AV Date de rupture de stock MIDAZOLAM Inj 5mg/mL 10x1mLA S OA BO TBD MIDAZOLAM Inj 5mg/mL 10x1mLV P OA AV MIDAZOLAM Inj 5mg/mL 10x2mLA S OA BO TBD MIDAZOLAM Inj 5mg/mL 10x2mLV P OA AV 5281 MIDAZOLAM Inj 5mg/mL 50mLV P OA AV 5370 MILRINONE Lactate Inj 1mg/mL 10x10mLV P OA AV 5530 MORPHINE HP50 Inj 50mg/mL 10x1mLV P OA AV 5560 MORPHINE HP50 Inj 50mg/mL 50mLV P OA AV 5550 MORPHINE HP50 Inj 50mg/mL 5x10mLV P OA AV MORPHINE LP EPID Inj 0.5mg/mL 10x10mLV P OA AV MORPHINE LP EPID Inj 1mg/mL 10x5mLV P OA AV 5442 MORPHINE SO4 Inj 10mg/mL 10x1mLA P OA AV MORPHINE SO4 Inj 10mg/mL 10x1mLA P OA AV 5452 MORPHINE SO4 Inj 15mg/mL 10x1mLA P OA AV 5642 MORPHINE SO4 Inj 2mg/mL 10x1mLA P OA AV 6401 MULTI-1000 Inj 10x10mLV P OA AV NALOXONE HCl Inj (SOS) 0.4mg/mL 10x1mLA P OA AV 5760 NALOXONE HCl Inj 0.4mg/mL 10mLV P OA AV 5750 NALOXONE HCl Inj 0.4mg/mL 10x1mLA P OA AV NALOXONE HCl Inj 0.4mg/mL 10x1mLA S OA BO TBD NALOXONE HCl Inj 1mg/mL 10x2mLV P OA AV 5972 NOREPINEPHRINE Bitart Inj 1mg/mL 10x4mLV P OA AV NUBAIN Inj 10mg/mL 10x1mLA P OA AV OLANZAPINE for Injection 1x10mg/V P OA BO Mid / mi ONDANSETRON Inj 2mg/mL 10x2mLV P OA AV ONDANSETRON Inj 2mg/mL 10x4mLV P OA AV ONDANSETRON Inj 2mg/mL 20mLV P OA AV ONDANSETRON Inj 2mg/mL 5x2mLA P OA AV ONDANSETRON Inj 2mg/mL 5x4mLA S OA BO TBD OXALIPLATIN Inj 5mg/mL 10mLV P OA BO End / Fin OXALIPLATIN Inj 5mg/mL 20mLV S OA BO N/A OXALIPLATIN Inj 5mg/mL 20mLV P OA BO Mid / mi OXALIPLATIN Inj 5mg/mL 30mLV P OA AV OXALIPLATIN Inj 5mg/mL 30mLV S OA BO TBD OXALIPLATIN Inj 5mg/mL 40mLV S OA BO N/A OXALIPLATIN Inj 5mg/mL 40mLV P OA BO Mid / mi PACLITAXEL Inj 6mg/mL 1x16.7mLV P OA AV PACLITAXEL Inj 6mg/mL 1x50mLV P OA ABO End / Fin PACLITAXEL Inj 6mg/mL 5x5mLV P OA BO Mid / mi PANTOPRAZOLE Na for Inj 10x40mgV P OA BO End / Fin Page 4

5 National Status for Injectables 9860 PAPAVERINE HCl Inj 32.5mg/mL 10x2mLV P OA AV PHENOBARBITAL Na Inj 120mg/mL 10x1mLA P OA AV Date de rupture de stock PHENOBARBITAL Na Inj 30mg/mL 10x1mLA P OA ABO End / Fin PHENTOLAMINE Mes Inj 5mg/mL 10x1mLV P OA AV 6171 PHENYLEPHRINE HCl Inj 10mg/mL 10x1mLV P OA AV 6181 PHENYLEPHRINE HCl Inj 10mg/mL 10x5mLV P OA AV 6200 PHENYTOIN Na Inj 50mg/mL 10x2mLV P OA AV 6211 PHENYTOIN Na Inj 50mg/mL 10x5mLV P OA AV PIPERACILLIN-TAZO for Inj 10x2.25gV P OA AV PIPERACILLIN-TAZO for Inj 10x3.375gV P OA AV PIPERACILLIN-TAZO for Inj 10x4.5gV P OA AV PIPERACILLIN-TAZO Inj PWD 13.5g/Vx P OA AV PROCAINAMIDE HCl Inj 100mg/mL 10x10mLV P OA AV 7000 PROPRANOLOL HCl Inj 1mg/mL 10x1mLV P OA AV 7060 PROTAMINE SO4 Inj 10mg/mL 10x5mLV P OA AV 7070 PROTAMINE SO4 Inj 10mg/mL 25mLV P OA AV 7250 RANITIDINE Inj 25mg/mL 10x2mLV P OA AV 7260 RANITIDINE Inj 25mg/mL 50mLV P OA AV ROCURONIUM Br Inj 10mg/mL 10x5mLV P OA AV 7870 SUFENTANIL Cit Inj 50mcg/mL 10x1mLA P OA AV SUFENTANIL Cit Inj 50mcg/mL 10x5mLV P OA AV TOBRAMYCIN INH SOL 300mg/5mL x 56 Amp P OA AV 8660 TOBRAMYCIN Inj 10mg/mL 10x2mLV P OA AV 8680 TOBRAMYCIN Inj 40mg/mL 30mLV P OA AV 8650 TOBRAMYCIN PF Inj 40mg/mL 10x2mLV P OA AV Topotecan HCl Inj. 1mg/mL 5x4mLV P OA BO End / Fin TRANEXAMIC ACID Inj 100mg/mL 10x10mLV P OA AV 8070 TRANEXAMIC ACID Inj 100mg/mL 50mLV P OA AV VANCOMYCIN HCl for Inj 10gV P OA BO TBD VANCOMYCIN HCl for Inj 1gx10V P OA AV VANCOMYCIN HCl for Inj 500mgx10V P OA ABO End / Fin VANCOMYCIN HCl for Inj 5gV P OA AV 8910 VASOPRESSIN Inj 20 USP units/ml 5mLV P OA BO End / Fin VASOTEC IV Inj 1.25mg/mL 2mLV P OA AV 8960 VERAPAMIL HCl Inj 2.5mg/mL 10x2mLV P OA AV 9051 VITAMIN B12 Inj 1000mcg/mL 10mLV P OA AV 9040 VITAMIN B12 Inj 1000mcg/mL 10x1mLA P OA AV 9060 VITAMIN B12 Inj 1000mcg/mL 30mLV P OA AV 9030 VITAMIN B12 Inj 100mcg/mL 10x1mLA D OA BO N/A 9040, 9051, VITAMIN C Inj 250mg/mL 10x2mLA P OA AV VORICONAZOLE for Inj 200mgV P OA AV ZOLEDRONIC ACID Inj 4mg/5mLV P OA AV Page 5

6 National Status for Injectables Sandoz Date de rupture de stock Legend Légende Description Description LIVI Liquid in vial Liquide en fiole LIAM Liquid in Ampoule Liquide en ampoule LYVI Lyophilisate in vial Lyophilisée en fiole PSOIJ Powder for solution for injection/ infusion Poudre pour solution injectable DIN: Leading zeros have been removed DIN: Les zéros non-significatifs du début ont été retirés Status produit P In production En production S Suspended format Format suspendu S1 Suspended format prioritized for return in production Format suspendu priorisé pour la remise en production D Discontinued Discontinué allocation rate OA Off allocation N'est pas en allocation Status AV Available Disponible ABO Anticipated backorder in the next 90 days Rupture de stock dans les prochains 90 jours BO On backorder En rupture de stock EM Emergency use only. Customers must order directly through Sandoz Canada by completing and submitting an "Exceeding Allocation Order" (EAO) form. Limited stock Cas d'urgence seulement. Les clients doivent commander directement chez Sandoz Canada en complétant le formulaire "Commande excédant les allocations" (CEA). Approvisionnement limité Insufficient stock Approvisionnement insuffisant & Additional Information week & information supplémentaire + Positive change on P product status since report positif de l'état P depuis le rapport (ex: increased allocation %, later stock depletion date, précédent (ex: taux augmenté, date de improved release date) rupture de stock repoussée, relâche devancée) négatif de l'état P depuis le rapport Negative change on P product status since report (ex: decreased allocation %, sooner stock depletion date, précédent (ex: taux réduit, date de rupture de stock devancée, relâche repoussée) later release date) Page 6

7 National Status for Injectables ABO definition Additional Information Anticipated backorder dates (ABO) are calculated based on projected national consumption. The actual backorder date at a customer's specific warehouse may differ from the ABO date indicated on this report. ABO - définition Information supplémentaire Les dates de ruptures de stock s (ABO) sont établies à partir d'une projection de consommation nationale. BO definition s are indicated as being on backorder (BO) as soon as the inventory level at the main Sandoz warehouse is less than a pre-determined threshold. There may still be inventory left in some warehouses. Customers are encouraged to verify the inventory status at their usual purchase point. BO - définition Les produits sont déclarés en rupture (BO) à partir du moment où le niveau d'inventaire dans l'entrepôt principal de Sandoz franchit un seuil pré-déterminé. Certains entrepôts à travers le pays peuvent encore avoir des quantités en inventaire. Les clients sont priés de vérifier le statut d'inventaire à leur point d'achat habituel. Processing of BO products in the allocation tables Where an alternative exists. Where an alternate product for a product on BO exists, the purchasing history of the BO product has been included in the purchasing history of the alternate product, with an adjustment in allocation for the alternate product. The transfer is now identifiable in the new column "Sandoz ", where the alternate product # is indicated. In the case of a temporary BO, the transfer of quantities is temporary and allocation quantities of the original product become available again once the original product returns in stock. Traitement des produits en rupture dans les tables Lorsqu'un produit de remplacement existe. Si un produit de remplacement existe au moment de la rupture d'un produit, l'historique d'achat en rupture est ajouté à l'historique d'achat de remplacement, ajustant à la hausse l'allocation de remplacement. Le transfert est indiqué dans la nouvelle colonne «Sandoz», où est inscrit le numéro de remplacement. Dans le cas d'une rupture temporaire, le transfert des quantités est temporaire et les quantités allouées pour le produit original seront rétablies lors de son retour en stock. Example: Exemple: When product 2090 CLINDAMYCIN 150MG/ML 1 vial x 120ML fell on BO, the sales history of that product was transferred to product 2080 CLINDAMYCIN 150MG/ML 1 vial x 60ML. Since the original format (120ml) contains twice as much volume as the alternate format (60ml), the transferred quantities were calculated as follows: façon suivante: Sales history of 2090 CLINDAMYCIN 150MG/ML 1 vial x 120ML: 100 units Historique d'achat de 2090 CLINDAMYCIN 150MG/ML 1 fiole x 120ML: Sales history of 2080 CLINDAMYCIN 150MG/ML 1 vial x 60ML: 400 units Historique d'achat de 2080 CLINDAMYCIN 150MG/ML 1 fiole x 60ML: Sales history of 2090 converted to equivalent quantities in 2080: 100 * 2 = 200 units Historique d'achat de 2090 converti en unités équivalentes du 2080: New sales history of 2080: = 600 units Nouvel historique d'achat de 2080: Lorsque le produit 2090 CLINDAMYCIN 150MG/ML 1 fiole x 120ML est tombé en rupture, son historique d'achat a été transféré au produit 2080 CLINDAMYCIN 150MG/ML 1 fiole x 60ML. Étant donné que le volume du format original (120ml) est deux fois plus grand que le volume du format de remplacement (60ml), le transfert de quantités a été calculé de la 100 unités 400 unités 100 * 2 = 200 unités = 600 unités Possible discrepancies between this report and quantities shipped to customers Depletion of suspended and discontinued products Where no alternative exists. s in production ("P" status) which are on short-term BO and for which an alternate product has NOT been identified are included in the allocation tables and continue to show quantities which can be ordered. Their inclusion is necessary to allow customers to order the product as soon as it becomes available again without having to wait for the following allocation cycle. Suspended or discontinued products. s that are suspended or discontinued ("S" and "D" status) which are on BO are removed from the allocation tables. Discrepancies may occur between the product status (ex: AV, BO) and allocation rate indicated on this report and actual quantities shipped. For example: - Some products on short-term BO continue to appear on the allocation tables (as described above). - Disruptions in the replenishment of the distribution centers may cause delays in having product available in time for the allocation cycles. Customers are encouraged to order the product again. Inventory depletion of suspended ("S" status) and discontinued ("D" status) products are indicated as follows: - The ABO is indicated when the backorder is anticipated to occur in the next 90 days (based on projected national consumption). - As soon as the inventory level at the main Sandoz warehouse is less than a pre-determined threshold, the status changes to BO and the product is removed from allocation (OA). There may still be inventory left in some warehouses, in which case customers will be able to order the remaining quantities until depletion at their purchase point. - The projected return date for suspended products is indicated in the " release"column. Différences possibles entre ce rapport et les quantités expédiées aux clients Écoulement des produits suspendus et discontinués Lorsqu'aucun produit de remplacement n'a été identifié. Les produits en production (statut «P») qui sont en rupture à court terme et pour lesquels aucun remplacement n'est disponible sont inclus dans les tables et continuent d'afficher des quantités qui peuvent être commandées. Ceci permet aux clients de commander le produit dès qu'il est disponible à nouveau sans devoir attendre le prochain cycle. s suspendus ou discontinués. Les produits suspendus ou discontinués (statuts «S» et «D») qui sont en rupture sont retirés des tables. Des divergences peuvent survenir entre le statut des produits (ex: AV, BO) et le taux indiqués dans ce rapport et les quantités réelles expédiées aux clients. Par exemple: - Certains produits qui sont en rupture à court terme continuent d'afficher des quantités dans les tables (tel que décrit précédemment). - Des interruptions dans le réapprovisionnement des entrepôts peuvent retarder la disponiblité des produits pour le cycle. Les clients sont priés de commander à nouveau. L'écoulement d'inventaire des produits suspendus (statut «S») et discontinués (statut «D») est indiqué de la façon suivante: - La rupture (ABO) est déclarée lorsqu'elle est au cours des 90 prochains jours (basé sur une projection de consommation nationale). - À partir du moment où le niveau d'inventaire dans l'entrepôt principal de Sandoz franchit un seuil pré-déterminé, le produit est déclaré en rupture (BO), puis est retiré de l'allocation (OA). Certains entrepôts à travers le pays peuvent encore avoir des produits en inventaire. Les clients pourront dans ce cas commander les quantités restantes jusqu'à épuisement des stocks à leur point d'achat. - La date de retour des produits suspendus est indiquée dans la colonne.